Minimally instrumented SHERLOCK (miSHERLOCK) for CRISPR-based point-of-care diagnosis of SARS-CoV-2 and emerging variants
Helena de Puig(Broad Institute), James J. Collins(Broad Institute), James B. Niemi, Angelo S. Mao(Harvard University), Luis R. Soenksen(Johns Hopkins University), Carlos F. Ng(Harvard University), Audrey Ory(Harvard University), Peter Q. Nguyen(Harvard University), Geoffrey Lansberry, Nicole E. Weckman(Harvard University), Devora Najjar(Human Media), Hani Sallum, Nicolaas M. Angenent-Mari(Harvard University), Xiao Tan(Broad Institute), Rose Lee(National Institutes of Health Clinical Center), Thomas C. Ferrante(Harvard University), Nina M. Donghia(Harvard University)
Cited by 333
Related Papers
Nucleic acid detection with CRISPR-Cas13a/C2c2
|Science|2017|3.9k
A Deep Learning Approach to Antibiotic Discovery
|Cell|2020|2.3k
Synthetic biology: applications come of age
|Nature Reviews Genetics|2010|1.4k
Definitions and guidelines for research on antibiotic persistence
|Nature Reviews Microbiology|2019|1.3k